Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-07-02-Speech-2-160"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20020702.7.2-160"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"Mr President, concerns about the effects of GMOs on human health are in the minds of many of us overshadowed by doubts about their effects upon other species of plants or animal life and about the control of the world's seed bank by a handful of companies. But it is animal and human health which is the issue before us and the ELDR Group is united in its belief that products need to be clearly labelled so that consumers can make proper choices.
We are, however, divided about the clearest way of achieving this result. A majority accept the Commission proposals but want products with more than 0.5% of GMOs or less if practicable, to be labelled as such. Traceability rules should be established so that this is done even when the presence of GMO DNA cannot be identified. But we risk overwhelming the consumer if we label every foodstuff made from products derived from animals fed on GMOs.
I am opposed to steps being taken which will eventually lead only to GMO-free or to non-GMO products being labelled if such a thing is possible, because this will result in normal foods being classified as special and transfer the burden of proof and costs away from GMO producers. We may have to do this eventually but not yet. GM crops have the potential to bring major benefits, but they also pose threats to the environment. Rules for trade are needed, but I will not be sorry if consumer preference slows the pace of GMO development and allows us more time to assess the full consequences of their use."@en1
|
| lpv:spokenAs | |
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples